North America Radiotherapy Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2030 |
 Marktgröße (Basisjahr) | |
 Marktgröße (Prognosejahr) | USD 6,322.46 |
 CAGR |
% |
| Wichtige Marktteilnehmer |
North America Radiotherapy Market, By Product and Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End-User (Hospitals, Radiation Therapy Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others) - Industry Trends and Forecast to 2030.
North America Radiotherapy Market Analysis and Size
North America incidence of cancer was on the rise, and radiotherapy is a crucial treatment modality for many cancer types. As the population continues to age and lifestyles change, the number of cancer cases was expected to increase, driving demand for radiotherapy. Increased awareness about cancer and its treatment options, along with improved screening and early detection methods, led to more individuals seeking cancer treatments, including radiotherapy. In many countries, healthcare spending has been increasing, providing more funding for advanced treatments like radiotherapy. Governments and private healthcare providers have been investing in upgrading their facilities and equipment.
Data Bridge Market Research analyzes that the North America radiotherapy market is expected to reach the value of USD 6,322.46 million by 2030, at a CAGR of 8.6% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product and Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, Others), End-User (Hospitals, Radiation Therapy Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others) |
|
Countries Covered |
U.S., Canada, Mexico |
|
Market Players Covered |
Elekta AB, Accuray Incorporated, IBA Worldwide, Eckert & Ziegler BEBIG, RaySearch Laboratories, Brainlab AG, Koninklijke Philips N.V., GE Healthcare, Hitachi, Ltd among others |
Market Definition
Radiotherapy is a type of treatment procedure that is mainly used for the treatment of cancer disease by the usage of X-rays along with similar forms of radiation technology. In radiotherapy treatment, high-energy-based radiation rays are often used to damage cancer cells and stop them from growing and dividing. Various types of software such as treatment planning software, dosage planning software, patient positioning software, image guiding software, and systemic radiotherapy among others are used in radiotherapy treatment planning. The treatment software program is used to calculate the dose of radiation which will be delivered to the patient's tumor and the surrounding normal tissue.
North America Radiotherapy Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growing Prevalence of Cancer Disease
The North America incidence of cancer continues to rise due to factors such as aging populations, lifestyle changes, environmental factors, and increased cancer awareness and screening. The demand for effective treatment options such as radiotherapy grows as more individuals are diagnosed with cancer. Radiotherapy can be used as a primary treatment for cancer, especially in cases where surgery is not feasible or as effective. It can also be used in conjunction with surgery, chemotherapy, or immunotherapy to enhance treatment outcomes. The versatility of radiotherapy makes it an essential tool in the comprehensive cancer treatment arsenal.
Cancer disease has a major impact North Americaly. Statistics on cancer describe that large groups of people have cancer across the world. Statistics show things that many people died from cancer each year. The treatment of radiotherapy can cure cancer symptoms. Radiation therapy uses high-energy particles or waves to kill the symptoms of cancer. Several people who are currently living with cancer require radiotherapy for cancer treatment. For this reason, the growing prevalence of cancer disease is acting as a driver for increasing the demand for the market.
- Novel Technology in Radiotherapy for Cancer Treatment
During the past several years, cancer radiotherapy has been largely driven by technological development. The technological development in radiotherapy is mainly focused on improving therapy procedures and launching new products which have advanced features that help in the treatment of cancer patients. This special issue aims at novel technological developments and has large potential in improving patient safety and treatment outcome in the radiotherapy management of cancers worldwide.
The modern and advanced technology-based radiotherapy procedure comprises the use of three-dimensional (3D) imaging technology, high-energy x-ray machines, and computerized treatment planning, which enhances the chances for more precise treatment possible. The increasing number of patients who successfully use radiation therapy due to technological advancement in radiotherapy and novel technology in radiotherapy for cancer treatment is expected to drive market growth.
Opportunity
- Increasing Healthcare Expenditure for Cancer Treatment
The government is continuously engaged in the activity of improving healthcare facilities to provide better health facilities and treatment to the patients such as improving cancer treatment procedures and increasing the number of radiotherapy treatment providers, among others. Growing healthcare expenditure is an opportunity for the market, because if investment in healthcare increases more people are getting aware of cancer disease and undergo advanced technology-based cancer treatment.
Continuously increasing healthcare expenditure help the end user to install the latest technology-based radiotherapy systems to improve efficiency, accuracy, and number of successful radiotherapy cancer treatments.
Restraint / Challenge
- Lack of Skilled and Certified Professionals
Radiotherapy is a type of complex procedure, operated by highly advanced radiotherapy products which deliver radiation explorer to a targeted point of the patient body to destroy the cancer cells. The radiotherapy procedure requires highly skilled and certified professionals as in this procedure, healthcare professionals have to decide the dosages of radiation delivered to the patient's body with the help of treatment planning software. Healthcare professionals need to be aware of how to handle these software and therapy modalities. The requirement for skilled and certified professionals is a big restraint for the market. The demand for cancer treatment is increasing due to continuously increasing cases of cancer disease across the world but a lack of skilled and certified professionals hampering the growth of the market.
North America Radiotherapy Market Scope
The north america radiotherapy market is segmented into five notable segments such as product and services, type, application, end-user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Services
- Product
- Software
On the basis of product and services, the market is segmented into services, product, and software
Type
- External-Beam Radiation Therapy
- Internal Radiation Therapy
- Systemic Radiotherapy/ Radiopharmaceuticals
- Others
On the basis of type, the market is segmented into external-beam radiation therapy, internal radiation therapy, systemic radiotherapy/ radiopharmaceuticals, and others
Application
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Lymphoma
- Liver Cancer
- Thyroid Cancer
- Brain Cancer
- Cervical Cancer
- Spine Cancer
- Others
On the basis of application, the market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, others
End-User
- Hospitals
- Radiation Therapy Centers
- Specialty Clinics
- Others
On the basis of end-user, the market is segmented into hospitals, radiation therapy centers, specialty clinics, and others.
Distribution Channel
- Direct Tenders
- Third Party Distributors
- Others
On the basis of distribution channel, the market is segmented into direct tenders, third party distributors, and others
North America Radiotherapy Market Regional Analysis/Insights
The North America radiotherapy market is analyzed and market size insights and trends are provided by product and services, type, application, end-user, and distribution channel as referenced above.
The countries covered in this market report are U.S., Canada, Mexico.
The rising prevalence of cancer and technological advancements are anticipated to fuel the market growth during the forecast period in this region. The U.S. is expected to dominate in North America as there is a rising demand for radiotherapy.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and North America Radiotherapy Market Share Analysis
The North America radiotherapy market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the company's focus related to the market.
Some of the major market players operating in the North America radiotherapy market are Elekta AB, Accuray Incorporated, IBA Worldwide, Eckert & Ziegler BEBIG, RaySearch Laboratories, Brainlab AG, Koninklijke Philips N.V., GE Healthcare, Hitachi, Ltd among others.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA RADIOTHERAPY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICES SEGMENT LIFELINE CURVE
2.8 MARKET END USERS COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 PRICING ANALYSIS
5 REGULATORY GUIDELINES FOR RADIOTHERAPY
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING PREVALENCE OF CANCER DISEASE
6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT
6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
6.2 RESTRAINTS
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.2.2 HIGH COST OF TREATMENT AND RADIOTHERAPY PROCEDURE
6.3 OPPORTUNITIES
6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT
6.3.2 GROWING GOVERNMENT INITIATIVES TOWARD CANCER TREATMENT
6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
6.4 CHALLENGES
6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
6.4.2 RISK OF RADIATION EXPOSURE
7 NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES
7.1 OVERVIEW
7.2 SERVICES
7.3 PRODUCT
7.4 SOFTWARE
8 NORTH AMERICA RADIOTHERAPY MARKET, BY TYPE
8.1 OVERVIEW
8.2 EXTERNAL-BEAM RADIATION THERAPY
8.3 INTERNAL RADIATION THERAPY
8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
8.5 OTHERS
9 NORTH AMERICA RADIOTHERAPY MARKET, BY APPLICATION
3.1 OVERVIEW 54
9.1 BREAST CANCER
9.2 LUNG CANCER
9.3 PROSTATE CANCER
9.4 COLORECTAL CANCER
9.5 LYMPHOMA
9.6 LIVER CANCER
9.7 THYROID CANCER
9.8 BRAIN CANCER
9.9 CERVICAL CANCER
9.1 SPINE CANCER
9.11 OTHERS
10 NORTH AMERICA RADIOTHERAPY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 RADIATION THERAPY CENTERS
10.4 SPECIALTY CLINICS
10.5 OTHERS
11 NORTH AMERICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDERS
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 NORTH AMERICA RADIOTHERAPY MARKET, BY REGION
12.1 OVERVIEW
12.2 NORTH AMERICA
12.2.1 U S
12.2.2 CANADA
12.2.3 MEXICO
13 NORTH AMERICA RADIOTHERAPY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 SIEMENS HEALTHCARE GMBH
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENT
15.2 ELEKTA
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENTS
15.3 GENERAL ELECTRIC COMPANY
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 HITACHI, LTD.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENT
15.5 KONINKLIJKE PHILIPS N.V.
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 ACCURACY INCORPORATED
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BEBIG MEDICAL.
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 BRAINLAB AG
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 CANON MEDICAL SYSTEMS CORPORATION
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 ECKERT & ZIEGLER BEBIG
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 IBA WORLDWIDE
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 LINATECH INC
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 MEVION MEDICAL SYSTEMS
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH)
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 P-CURE
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 SHINVA MEDICAL INSTRUMENT CO., LTD.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 UNITED IMAGING HEALTHCARE CO., LTD
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”)
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENT
15.19 ZEISS INTERNATIONAL
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 NORTH AMERICA RADIOTHERAPY MARKET: AVERAGE SELLING PRICE OF EQUIPMENT, SOFTWARE AND SERVICES
TABLE 2 NORTH AMERICA RADIOTHERAPY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 16 U.S. RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 17 U.S. PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 18 U.S. EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 19 U.S. PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 20 U.S. INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 21 U.S. SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 22 U.S. SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 23 U.S. RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 24 U.S. EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 25 U.S. INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 26 U.S. RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 27 U.S. RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 28 U.S. RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 29 CANADA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 30 CANADA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 31 CANADA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 32 CANADA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 33 CANADA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 34 CANADA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 35 CANADA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 36 CANADA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 37 CANADA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 CANADA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 39 CANADA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 40 CANADA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 41 CANADA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 42 MEXICO RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 43 MEXICO PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 44 MEXICO EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 45 MEXICO PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 46 MEXICO INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 47 MEXICO SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 48 MEXICO SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 49 MEXICO RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 50 MEXICO EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 51 MEXICO INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 52 MEXICO RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 53 MEXICO RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 54 MEXICO RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 NORTH AMERICA RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA RADIOTHERAPY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA RADIOTHERAPY MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA RADIOTHERAPY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA RADIOTHERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA RADIOTHERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA RADIOTHERAPY MARKET: MARKET END USERS COVERAGE GRID
FIGURE 8 NORTH AMERICA RADIOTHERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA RADIOTHERAPY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 11 THE RISING PREVALENCE OF CANCER AND GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES ARE EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA RADIOTHERAPY MARKET FROM 2023 TO 2030
FIGURE 12 THE SERVICES SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA RADIOTHERAPY MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA RADIOTHERAPY MARKET
FIGURE 14 NORTH AMERICA RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2022
FIGURE 15 NORTH AMERICA RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 18 NORTH AMERICA RADIOTHERAPY MARKET: BY TYPE, 2022
FIGURE 19 NORTH AMERICA RADIOTHERAPY MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA RADIOTHERAPY MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA RADIOTHERAPY MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA RADIOTHERAPY MARKET: BY APPLICATION, 2022
FIGURE 23 NORTH AMERICA RADIOTHERAPY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA RADIOTHERAPY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA RADIOTHERAPY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA RADIOTHERAPY MARKET: BY END USER, 2022
FIGURE 27 NORTH AMERICA RADIOTHERAPY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA RADIOTHERAPY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA RADIOTHERAPY MARKET: BY END USER LIFELINE CURVE
FIGURE 30 NORTH AMERICA RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 NORTH AMERICA RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA RADIOTHERAPY MARKET: SNAPSHOT (2022)
FIGURE 35 NORTH AMERICA RADIOTHERAPY MARKET: BY REGION (2022)
FIGURE 36 NORTH AMERICA RADIOTHERAPY MARKET: BY REGION (2023 & 2030)
FIGURE 37 NORTH AMERICA RADIOTHERAPY MARKET: BY REGION (2022 & 2030)
FIGURE 38 NORTH AMERICA RADIOTHERAPY MARKET: BY PRODUCT & SERVICES (2023-2030)
FIGURE 39 NORTH AMERICA RADIOTHERAPY MARKET: COMPANY SHARE 2022 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
